X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 31/10/2024 00:10

Monthly News Roundup - October 2024

FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev (foscarbidopa and foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson...

Articles similaires

Sorry! Image not available at this time

Monthly News Roundup - December 2024

drugs.com - 31/12/2024 22:12

FDA Approves Zepbound as the First Prescription Drug for Obstructive Sleep Apnea in Adults with Obesity On December 20, 2024, the U.S. Food and Drug...

Sorry! Image not available at this time

FDA Approves Symvess, an Acellular Tissue-Engineered Vessel

drugs.com - 02/Jan 16:01

THURSDAY, Jan. 2, 2025 -- The U.S. Food and Drug Administration has approved Symvess, the first acellular tissue engineered vessel indicated for use...

Sorry! Image not available at this time

FDA approves first drug for sleep apnea treatment

knowridge.com - 30/12/2024 11:04

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug specifically for treating...

Sorry! Image not available at this time

FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications

drugs.com - 03/Jan 16:01

FRIDAY, Jan. 3, 2025 -- The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for...

Sorry! Image not available at this time

FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications

drugs.com - 03/Jan 16:01

FRIDAY, Jan. 3, 2025 -- The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for...

Sorry! Image not available at this time

Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease

drugs.com - 08/Jan 22:01

TITUSVILLE, N.J., January 8, 2025 -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted...

Sorry! Image not available at this time

Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease

drugs.com - 08/Jan 22:01

TITUSVILLE, N.J., January 8, 2025 -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted...

Sorry! Image not available at this time

FDA Approves Gemtesa for Overactive Bladder in Men With BPH

drugs.com - 02/Jan 22:39

THURSDAY, Jan. 2, 2025 -- Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB)...

Sorry! Image not available at this time

GSK’s B7-H3-Targeted Antibody-Drug Conjugate, GSK’227, Receives US FDA Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma

drugs.com - 07/Jan 22:01

London, UK January 07 2025 -- GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy...

Sorry! Image not available at this time

GSK’s B7-H3-Targeted Antibody-Drug Conjugate, GSK’227, Receives US FDA Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma

drugs.com - 07/Jan 22:01

London, UK January 07 2025 -- GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy...

Les derniers communiqués